Abstract
Endocrine therapy is the most elegant form of treatment for breast cancer as it uses the body’s own mechanisms to fight the cancer and is less invasive or toxic than other methods. The ‘mechanisms’ behind this treatment give an insight into the nature of breast cancer, and so may lead to better understanding of the causes of the disease and thus the possibility of preventing it.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beatson, G.T. (1896) On the management of inoperable cases of carcinoma of the mamma: suggestion for new method of treatment with illustrative cases. Lancet, 2, 104–7, 162–5.
Casey, A. (1981) Oestrogen receptor and breast cancer. Nursing Times, 16 April.
Cavalli, F. (1989) Endocrine Therapy of Breast Cancer III, Springer-Verlag, Berlin.
Crichlow, R.W. and Evans, D.B. (1987) Cancer in the Male Breast, in Breast Cancer: Diagnosis and Treatment (ed. I. Ariel and J. Cleary), McGraw-Hill, New York.
Dunne, C.F. (1988) Hormonal therapy for breast cancer. Cancer Nursing 11(5), 288–94.
Early Breast Cancer Trialist’s Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. The Lancet, 339(8784), 1–15.
Feldman, J.E. (1989) Ovarian failure and cancer treatment: incidence and interventions for the premenopausal woman. Oncology Nursing Forum, 16(5), 651–7.
Furr, B.J.A. and Milsted, R.A.V. (1988) LH-RH Analogues in Cancer Treatment in Endocrine Management of Cancer: Volume 2 Contemporary Therapy (ed. B. Stoll), Karger, Basle.
Goodman, M. (1988) Concepts of hormonal manipulation in the treatment of cancer. Oncology Nursing Forum, 15(5), 639–47.
Howie, C. (1987) Sparing the flushes. Nursing Times, 83(49), 51–3.
Huggins, C. and Bergenstal, D.M. (1952) Inhibition of human mammary and prostatic cancer by adrenalectomy. Cancer Research, 12, 134–41.
Jordan, V.C. (1986) Estrogen/Antiestrogen Action and Breast Cancer Therapy, Wisconsin Press, Madison.
Jordan, V.C. and Morrow, M. (1994) Should clinicians be concerned about the carcinogenic potential of tamoxifen? European Journal of Cancer, 30A(11), 1714–21.
Levine-Silverman, S. (1989) The menopausal hot flash: a procrustean bed of research. Journal of Advanced Nursing, 14, 939–49.
Osborne, C.K. (1985) Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Seminars in Oncology, 12(1), supplement 1, 12–16.
Padmanabhan, N., Howell, A. and Rubens, R.D. (1986) Mechanism of action of adjuvant chemotherapy in early breast cancer. The Lancet, ii, 411–14.
Powles, T.J. (1983) The role of aromatase inhibitors in breast cancer. Seminars in Oncology, 10, supplement 4, 4.
Sque, M. (1985) What’s in a name? Nursing Mirror, 160(8), 22.
Stewart, HJ. (1992) Scottish Cancer Trials Breast Group — The Scottish trial of adjuvant tamoxifen in node negative breast cancer. Monogr. National CancerInstitute, 11, 117–20.
Vallis, K. and Waxman, J. (1988) Tumour Flare in Hormonal Therapy, in Endocrine Management of Cancer; Volume 2 Contemporary Therapy (ed. B. Stoll), Karger, Basle.
Voda, A. (1986) Menopause. Annual Review of Nursing Research, 4, 55–75.
Webb, C. (1985) Sexuality, Nursing and Health, J. Wiley and Sons, Chichester.
Editor information
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fenlon, D. (1996). Endocrine therapies for breast cancer. In: Denton, S. (eds) Breast Cancer Nursing. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3388-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3388-1_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-41200-4
Online ISBN: 978-1-4899-3388-1
eBook Packages: Springer Book Archive